Mallotusinin

Details

Top
Internal ID 2c582e3e-7fec-4c4c-8657-903b3411cb47
Taxonomy Phenylpropanoids and polyketides > Tannins > Hydrolyzable tannins
IUPAC Name [(8R,9S,27R,29S,30R)-2,3,14,15,16,19,20,21,35,36-decahydroxy-6,11,24,32-tetraoxo-7,10,25,28,31,40-hexaoxaoctacyclo[35.2.1.05,39.08,27.09,30.012,17.018,23.033,38]tetraconta-1(39),2,4,12,14,16,18,20,22,33,35,37-dodecaen-29-yl] 3,4,5-trihydroxybenzoate
SMILES (Canonical) C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7=C(O6)C(=C(C=C7C(=O)O3)O)O)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O
SMILES (Isomeric) C1[C@@H]2[C@@H]3[C@@H]([C@H]([C@@H](O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7=C(O6)C(=C(C=C7C(=O)O3)O)O)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O
InChI InChI=1S/C41H26O25/c42-13-1-8(2-14(43)24(13)48)36(55)66-41-35-34-31(63-39(58)11-5-17(46)27(51)32-22(11)23-12(40(59)65-35)6-18(47)28(52)33(23)62-32)19(61-41)7-60-37(56)9-3-15(44)25(49)29(53)20(9)21-10(38(57)64-34)4-16(45)26(50)30(21)54/h1-6,19,31,34-35,41-54H,7H2/t19-,31-,34+,35-,41+/m1/s1
InChI Key SHIKPQXKXYEXCO-RWKQGRNFSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C41H26O25
Molecular Weight 918.60 g/mol
Exact Mass 918.07631631 g/mol
Topological Polar Surface Area (TPSA) 417.00 Ų
XlogP 2.90
Atomic LogP (AlogP) 2.47
H-Bond Acceptor 25
H-Bond Donor 13
Rotatable Bonds 2

Synonyms

Top
SCHEMBL3248542
SHIKPQXKXYEXCO-RWKQGRNFSA-
[decahydroxy(tetraoxo)[?]yl] 3,4,5-trihydroxybenzoate
InChI=1/C41H26O25/c42-13-1-8(2-14(43)24(13)48)36(55)66-41-35-34-31(63-39(58)11-5-17(46)27(51)32-22(11)23-12(40(59)65-35)6-18(47)28(52)33(23)62-32)19(61-41)7-60-37(56)9-3-15(44)25(49)29(53)20(9)21-10(38(57)64-34)4-16(45)26(50)30(21)54/h1-6,19,31,34-35,41-5

2D Structure

Top
2D Structure of Mallotusinin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7660 76.60%
Caco-2 - 0.8806 88.06%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.7109 71.09%
OATP2B1 inhibitior + 0.5774 57.74%
OATP1B1 inhibitior + 0.7459 74.59%
OATP1B3 inhibitior + 0.9134 91.34%
MATE1 inhibitior - 0.5000 50.00%
OCT2 inhibitior - 0.8000 80.00%
BSEP inhibitior + 0.8904 89.04%
P-glycoprotein inhibitior + 0.7585 75.85%
P-glycoprotein substrate - 0.6074 60.74%
CYP3A4 substrate + 0.6249 62.49%
CYP2C9 substrate - 0.8059 80.59%
CYP2D6 substrate - 0.8523 85.23%
CYP3A4 inhibition - 0.7885 78.85%
CYP2C9 inhibition - 0.7569 75.69%
CYP2C19 inhibition - 0.6946 69.46%
CYP2D6 inhibition - 0.8850 88.50%
CYP1A2 inhibition - 0.7339 73.39%
CYP2C8 inhibition + 0.6636 66.36%
CYP inhibitory promiscuity - 0.8019 80.19%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6038 60.38%
Eye corrosion - 0.9900 99.00%
Eye irritation - 0.8691 86.91%
Skin irritation - 0.7829 78.29%
Skin corrosion - 0.9483 94.83%
Ames mutagenesis + 0.5536 55.36%
Human Ether-a-go-go-Related Gene inhibition + 0.8051 80.51%
Micronuclear + 0.8133 81.33%
Hepatotoxicity - 0.5500 55.00%
skin sensitisation - 0.7784 77.84%
Respiratory toxicity + 0.5778 57.78%
Reproductive toxicity + 0.7333 73.33%
Mitochondrial toxicity + 0.6250 62.50%
Nephrotoxicity - 0.8782 87.82%
Acute Oral Toxicity (c) III 0.5354 53.54%
Estrogen receptor binding + 0.8008 80.08%
Androgen receptor binding + 0.7458 74.58%
Thyroid receptor binding + 0.5273 52.73%
Glucocorticoid receptor binding + 0.6090 60.90%
Aromatase binding - 0.5223 52.23%
PPAR gamma + 0.7470 74.70%
Honey bee toxicity - 0.7600 76.00%
Biodegradation - 0.9250 92.50%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.9202 92.02%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.95% 91.11%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 92.85% 94.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.46% 89.00%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 91.79% 83.00%
CHEMBL1293267 Q9HC97 G-protein coupled receptor 35 91.59% 89.34%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 91.15% 95.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.81% 86.33%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 90.74% 99.23%
CHEMBL3194 P02766 Transthyretin 90.07% 90.71%
CHEMBL1951 P21397 Monoamine oxidase A 89.90% 91.49%
CHEMBL4657 Q6V1X1 Dipeptidyl peptidase VIII 89.01% 97.21%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.41% 95.56%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 86.15% 96.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.53% 99.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.84% 95.89%
CHEMBL2581 P07339 Cathepsin D 83.53% 98.95%
CHEMBL340 P08684 Cytochrome P450 3A4 83.22% 91.19%
CHEMBL2094127 P06493 Cyclin-dependent kinase 1/cyclin B 82.88% 96.00%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 82.52% 96.21%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 81.97% 95.64%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 81.00% 99.15%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 80.88% 92.62%
CHEMBL3864 Q06124 Protein-tyrosine phosphatase 2C 80.40% 94.42%

Cross-Links

Top
PubChem 514180
NPASS NPC86136
LOTUS LTS0231544
wikiData Q104396777